Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rain Therapeutics Q3 EPS $(0.70) Up From $(3.05) YoY

Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.70) per share. This is a 77.05 percent increase over losses of $(3.05) per share from the same period last year.
byBenzinga Newsdesk
November 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.70) per share. This is a 77.05 percent increase over losses of $(3.05) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Avangrid: Q3 Earnings Insights

By Benzinga Insights
Today, 6:25 AM
Avangrid (NYSE:AGR) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Avangrid beat their estimated earnings by 17.24%, which surprised analysts.

AGR

Read More

CalAmp Earnings Preview

By Benzinga Insights
Today, 6:25 AM
CalAmp (NASDAQ:CAMP) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that CalAmp will report an earnings per share (EPS) of $-0.03.

CAMP